Las Vegas, NV -- (SBWIRE) -- 01/08/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Cereplast, Inc. (PINK:CERP) is currently trading at $0.0230, 4.17% lower. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Can CERP Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=CERP
FreeSeas Inc. (NASDAQ:FREE) added 130.77% to $0.510. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company owns nine vessels, each of which is owned through a separate wholly owned subsidiary. Its fleet consists of five Handysize vessels and two Handymax vessels that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as major bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
To Get complete technical analysis on FREE go to http://beststocksdaily.com/p2/index.php?company=FREE
Generex Biotechnology Corporation (OTC:GNBT) is higher 39.41% to $0.0375. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world. The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.
Get Free Trend Analysis on GNBT Here http://beststocksdaily.com/p2/index.php?company=GNBT
Rexahn Pharmaceuticals, Inc. (NYSE:RNN) among the gainers and the stock added 1.04% to $0.351. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development .
To Get complete technical analysis on RNN go to http://beststocksdaily.com/p2/index.php?company=RNN
Motricity Inc(NASDAQ:MOTR) added 8.87% to $0.463. Motricity, Inc. provides mobile content through consumer Websites and channel partnerships. The Company provides mobile content infrastructure to the wireless industry. Motricity provides mobile content delivery solutions for consumers and business partners from games to business applications, and from ringtones to electronic books.
Get Free Trend Analysis on MOTR Here http://beststocksdaily.com/p2/index.php?company=MOTR
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)